BIORA THERAPEUTICS, INC. (BIOR) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Biora Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Biora Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$955 M, a 13.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$955 M -$111 M -13.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$951 M -$124 M -15% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$936 M -$122 M -15.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$862 M -$54.1 M -6.69% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$844 M -$41.8 M -5.21% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$827 M -$38.2 M -4.84% Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$813 M -$117 M -16.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$808 M -$156 M -23.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$802 M -$229 M -39.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$789 M -$247 M -45.7% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$696 M -$230 M -49.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$652 M -$233 M -55.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$574 M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$541 M -$193 M -55.3% Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$466 M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$419 M Jun 30, 2020 10-Q 2020-08-14
Q4 2019 -$348 M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.